Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: Potential for use in a broad-spectrum vaccine

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 2144-2150

  Lebens, M ^a   Shahabi, V ^a   Backstrom M ^a   Houze, T ^a   Lindblad, M ^a   Holmgren, J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; HYBRID PROTEIN; MUTANT PROTEIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHO CELL; CROSS REACTION; DIARRHEA; ESCHERICHIA COLI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; VACCINE PRODUCTION; VIBRIO CHOLERAE;

EID: 0029933633     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.2144-2150.1996     Document Type: Article

References (33)

1. Åhren, C., C. Wennerås, J. Holmgren and A.-M. Svennerholm. 1993. Intestinal antibody response after oral immunisation with a prototype B subunit-CFA enterotoxigenic Escherichia coli vaccine. Vaccine 11:929-935.
2. Black, R. E. 1986. The epidemiology of cholera and enterotoxigenic E. coli diarrheal diseases, p. 23-32. In J. Holmgren, A. Lindberg, and R. Mölby (ed.), Development of vaccines and drugs against diarrhea. Proceedings of the 11th Nobel Conference. Studentlitteratur, Lund, Sweden.
3. Clemens, J., D. Sack, J. R. J. Harris, J. Chakraborty, P. K. Neogy, B. Stanton, N. Huda, M. U. Khan, B. A. Kay, M. R. Khan, M. Ansaruzzaman, M. Yunus, M. R. Rao, A.-M. Svennerholm, and J. Holmgren. 1988. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic E. coli: results of a large field trial. J. Infect. Dis. 158:372-377.
4. Clemens, J., D. Sack, J. R. J. Harris, F. van Loon, J. Chakraborty, F. Ahmed, M. R. Rao, M. R. Khan, M. Yunus, N. Huda, B. Stanton, B. A. Kay, S. Walter, R. Eeckels, A.-M. Svennerholm, and J. Holmgren. 1988. Field trials of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet i:270-273.
5. Domenighini, M., M. Pizza, M. G. Jobling, R. K. Holmes, and R. Rappuoli. 1995. Identification of errors among the database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxin of Escherichia coli and Vibrio cholerae. Mol. Microbiol. 15:1165-1167.
6. Guerrant, R. L., L. L. Brunton, R. C. Schnaitman, L. I. Rebhun, and A. G. Gliman. 1974. Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for enterotoxins of Vibrio choleme and Escherichia coli. Infect. Immun. 10:320-327.
7. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature (London) 292:413-417.
8. 7a. Holmgren, J., et al. Unpublished data.
9. Holmgren, J., P. Fredman, M. Lindblad, A.-M. Svennerholm, and L. Svennerholm. 1982. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect. Immun. 38: 424-433.
10. Holmgren, J., A.-M. Svennerholm, M. Jertborn, J. Clemens, D. A. Sack, R. Salenstedt, and H. Wigzell. 1992. An oral B subunit: whole cell vaccine against cholera. Vaccine 10:911-914.
11. Institute of Medicine. 1986. New vaccine development, establishing priorities, vol. II. Diseases of importance in developing countries. National Academy Press, Washington, D.C.
12. Kaper, J. B., H. Lockman, M. M. Baldini, and M. M. Levine. 1984. Recombinant nontoxigenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature (London) 308:655-658.
13. Lebens, M., and J. Holmgren. Unpublished data.
14. Lebens, M., S. Johansson, J. Osek, M. Lindblad, and J. Holmgren. 1993. Overexpression of recombinant cholera toxin B subunit for use in oral vaccines. Bio/Technology 11:1574-1578.
15. Leong, J., A. C. Vinal, and W. S. Dallas. 1985. Nucleotide sequence comparison between heat-labile toxin B subunit cistrons from Escherichia coli of human and porcine origin. Infect. Immun. 48:73-78.
16. Merrit, E. A., S. Sarfaty, F. van den Akker, C. L'Hoir, J. A. Martial, and W. G. J. Hol. 1994. Crystal structure of cholera toxin B pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 3:166-175.
17. Peltola, H., A. Siitonen, H. Kyrönseppä, I. Simula, L. Mattila, P. Oksanen, M. J. Kataja, and M. Cadoz. 1991. Prevention of travellers' diarrhoea by oral B subunit/whole cell cholera vaccine. Lancet 338:1285-1289.
18. Quiding, M., I. Nordström, A. Kilander, G. Andersson, L.-Å. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and invokes immunological memory. J. Clin. Invest. 88:143-148.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
20. Sanchez, J., and J. Holmgren. 1989. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86:481-485.
21. Sandkvist, M., T. Hirst, and M. Bagdasarian. 1987. Alterations at the carboxyl terminus change assembly and secretion properties of the B subunit of Escherichia coli heat-labile enterotoxin. J. Bacteriol. 169:4570-4576.
22. Schödel, F., D. R. Milich, and H. Will. 1991. Hybrid hepatitis B virus core/ pre-S particles expressed in attenuated Salmonellae for oral immunisation, p. 319-325. In F. Brown, R. M. Chanock, H. S. Ginsberg, and R. A. Lerner (ed.), Vaccines 91. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Sixma, T. K., K. H. Kalk, B. A. M. van Zanten, Z. Dauter, J. Kingma, B. Witholt, and W. G. J. Hol. 1993. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J. Mol. Biol. 230:890-918.
24. Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartner, B. A. M. van Zanten, B. Witholt, and W. G. J. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature (London) 351:371-378.
25. Spangler, B. D. 1992. Structure and function of cholera toxin and the related heat-labile enterotoxin of Escherichia coli. Microbiol. Rev. 56:622-647.
26. Svennerholm, A.-M., C. Åhren, C. Wennerås, and J. Holmgren. 1991. Development of an oral vaccine against enterotoxigenic E. coli diarrhea, p. 287-294. In T. Wadström, H. Mekele, A.-M. Svennerholm, and H. Wolf-Watz (ed.), Molecular pathogenesis of gastrointestinal infections. Plenum Press, London.
27. Svennerholm, A.-M., L. Gothefors, D. A. Sack, P. K. Bardhan, and J. Holmgren. 1984. Local and systemic antibody responses and immunological memory in humans after immunization with cholera toxin B subunit by different routes. Bull. W.H.O. 62:909-918.
28. Svennerholm, A.-M., and J. Holmgren. 1976. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/ toxoid. Infect. immun. 13:735-740.
29. Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1 ELISA) procedure. Curr. Microbiol. 1:19-23.
30. Svennerholm, A.-M., J. Holmgren, R. Black, M. Levine, and M. M. Merson. 1983. Serologic differentiation between antitoxic responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 147: 514-522.
31. Svennerholm, A.-M., M. Jertborn, L. Gothefors, A. M. M. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunitwhole cell vaccine. J. Infect. Dis. 149:884-893.
32. Svennerholm, A.-M., D. A. Sack, J. Holmgren, and P. K. Bardhan. 1982. Intestinal antibody responses after immunization with cholera toxin B subunit. Lancet i:305-308.
33. Svennerholm, A.-M., M. Wickström, M. Lindblad, and J. Holmgren. 1986. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med. Biol. 64:23-30.